Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Zeljka Minic
 -- 2218 2023-04-11 14:54:44 |
2 Reference format revised.
Lindsay Dong
Meta information modification 2218 2023-04-13 08:43:26 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Reynolds, C.A.; Minic, Z. Sympathetic Nerve in Chronic Pain-Associated Cardiovascular Disease. Encyclopedia. Available online: https://encyclopedia.pub/entry/42946 (accessed on 17 May 2024).
Reynolds CA, Minic Z. Sympathetic Nerve in Chronic Pain-Associated Cardiovascular Disease. Encyclopedia. Available at: https://encyclopedia.pub/entry/42946. Accessed May 17, 2024.
Reynolds, Christian A., Zeljka Minic. "Sympathetic Nerve in Chronic Pain-Associated Cardiovascular Disease" Encyclopedia, https://encyclopedia.pub/entry/42946 (accessed May 17, 2024).
Reynolds, C.A., & Minic, Z. (2023, April 11). Sympathetic Nerve in Chronic Pain-Associated Cardiovascular Disease. In Encyclopedia. https://encyclopedia.pub/entry/42946
Reynolds, Christian A. and Zeljka Minic. "Sympathetic Nerve in Chronic Pain-Associated Cardiovascular Disease." Encyclopedia. Web. 11 April, 2023.
Sympathetic Nerve in Chronic Pain-Associated Cardiovascular Disease
Edit
This entry is adapted from the peer-reviewed paper 10.3390/ijms24065378

Chronic pain affects many people world-wide, and this number is continuously increasing. There is a clear link between chronic pain and the development of cardiovascular disease through activation of the sympathetic nervous system.

sympathetic nerve activity chronic pain cardiovascular disease

1. Sympathetic Nervous System and Cardiovascular Disease

The SNS is critical for general cardiovascular homeostasis [1] as it exerts direct actions on heart rate and cardiac contractility as well as venous capacitance, arteriolar resistance, and blood volume (via sodium and water balance in the kidneys). However, excessive SNS activation increases cardiovascular morbidity and mortality [1][2]. Acute overactivation of the SNS can manifest as adverse cardiac events including: ventricular arrhythmias, myocardial infarction, atrial fibrillation, stroke, and Takotsubo cardiomyopathy [2]. Chronic overactivation of the SNS leads to hypertension, ischemic heart disease, heart failure, and renal failure [1].
In chronic pain, cardiovascular indices that indicate SNS overactivation, including increased blood pressure and heart rate, have been well documented [3][4][5][6][7]. Additionally, SNS overactivation contributes to the process of atherosclerosis by inducing platelet activation [8][9][10] and promoting mechanical injury to the vascular endothelial cells because of increased blood pressure and flow velocity. At the level of the heart, the ensuing atherosclerosis manifests with coronary artery disease and can trigger myocardial infarction. Furthermore, chronic, and excessive sympathetic drive to the heart (i) limits myocardial oxygen delivery via coronary vasoconstriction, while also (ii) increasing myocardial oxygen demand because of increased energy utilization.

2. Basic Neurocircuitry of the Sympathetic Nervous System

Sympathetic preganglionic neurons are cholinergic neurons located within the intermediolateral (IML) cell column of the spinal cord. These neurons innervate pre- and para-vertebral ganglia where they synapse with adrenergic postganglionic neurons. One exception is the adrenal gland, which is directly innervated by sympathetic preganglionic neurons and drives the systemic release of epinephrine. The regulation of sympathetic preganglionic neuron-firing is influenced by various interconnected neuronal networks, including: (i) the central autonomic network providing descending projections from the brain, and (ii) the intraspinal network consisting of propriospinal neurons and spinal interneurons. The level of sympathetic activity targeting the effector organs is ultimately determined by the balance of excitatory and inhibitory inputs to sympathetic preganglionic neurons in the IML.
The central autonomic network serves an essential physiological role in the coordinated, real-time adaptations of SNS in response to external and internal stimuli. Brain regions, which comprise the central autonomic network include: (i) brainstem centers (both medulla and midbrain), (ii) diencephalon, and (iii) cortical sites; all of which work in a coordinated manner to influence sympathetic tone and cardiovascular function [11]. Arguably, to date, most is known about the role of brainstem centers in controlling SNA. It was over 100 years ago when the rostral ventrolateral medulla (RVLM) was first identified as a primary regulator of sympathetic tone [12][13] as bilateral lesioning or pharmacological blockade of the ventrolateral medulla produced decreases in sympathetic activity and arterial hypotension [12][13][14]. Since then, many studies have substantiated this initial observation and highlighted the RVLM as one of the most important sources of descending excitatory drive to sympathetic preganglionic neurons located in the IML [15][16][17][18][19]. Additionally, the RVLM and adjacent brainstem centers are involved in baroreflex processing, which is critical for quick reflex-mediated changes in SNA (Figure 1). Afferent neurons innervating the carotid sinus and aortic arch carry afferent, baroreceptor-related information, to the medulla, via the vagal and glossopharyngeal nerves. During baroreceptor loading, as occurs during increases in blood pressure, the nucleus of the solitary tract (NTS) receives excitatory glutamatergic input from these afferent neurons and activates inhibitory GABAergic neurons within the caudal ventrolateral medulla (CVLM). The CVLM, in turn, inhibits RVLM neurons and decreases the excitatory drive to the sympathetic preganglionic neurons located in the IML. It is important to note that in addition to decreasing excitatory RVLM drive, baroreceptor loading increases descending inhibitory drive to sympathetic preganglionic neurons located in the IML [20][21][22]. Such descending inhibitory projections may arise from nuclei of the CVLM, the reticular formation, or the locus coeruleus (LC), which also receive direct projections from barosensitive NTS neurons. While the central neural networks involved in driving descending inhibition of IML neurons are not well defined, in response to baroreceptor loading, SNA can be reduced to levels similar to those observed following ganglionic blockade (Figure 2, panel A), which is well below the levels recorded following bilateral pharmacological inhibition of RVLM [23] or spinal cord transection (Figure 2, panel B) [24][25][26][27]. These data suggest that: (i) intraspinal networks alone can maintain baseline SNA tone and blood pressure and that (ii) the inhibition of SNA in response to baroreceptor loading (phenylephrine infusion) originates from within the supraspinal centers, possibly the LC or other brainstem centers.
/media/item_content/202304/6437a38b565d6ijms-24-05378-g001.png
Figure 1. Control of sympathetic preganglionic neurons. Efferent sympathetic nerve activity (SNA) is determined by the net product of excitatory and inhibitory projections to sympathetic preganglionic neurons located within the intermediolateral (IML) cell column of the thoracic spinal cord. The rostral ventrolateral medulla (RVLM) is one of the main sources of descending excitatory drive (green). Additionally, second-order sensory neurons, relaying information from primary sensory afferents, are an important intraspinal source of excitatory drive to sympathetic preganglionic neurons. Descending inhibitory projections to sympathetic preganglionic neurons (red) arise from multiple brain regions including from the locus coeruleus (LC) and the reticular formation (RF). Much of the descending excitatory and inhibitory drive to sympathetic preganglionic neurons is regulated by neurons located within the nucleus of the solitary tract (NTS), which is the primary integrative site for baroreceptor and chemoreceptor afferent fibers which drive autonomic reflexes. Included above is an example of raw (lower tracing) and integrated (upper tracing) SNA recorded from postganglionic renal sympathetic nerve fibers in a rat as described in [24] (lower right).
/media/item_content/202304/6437a39e7b952ijms-24-05378-g002.png
Figure 2. Baroreceptor loading strongly inhibits sympathetic nerve activity. Responses in arterial pressure (AP) and renal sympathetic nerve activity (RSNA) to intravenous administration of phenylephrine (40 µg/kg) in (A) spinal intact and (B) T4 spinal-transected rats. The red line in the top panel represents the level of recorded activity (zero) at the end of the experiment following ganglionic blockade (hexamethonium, 20 mg/kg). See text for additional information.
In addition to reflex regulation, cognitive processing and emotion regulation are important drivers of sympathetic activity involving the central autonomic network. Classical cardiovascular responses to emotional stress (fight and flight response or defense reaction) are produced by disinhibition of the paraventricular and dorsomedial nuclei of the hypothalamus and drive sympathoexcitatory responses and increases in blood pressure (Figure 3) [28][29][30].
/media/item_content/202304/6437a3af0199fijms-24-05378-g003.png
Figure 3. Central autonomic network. Depicted is the neural circuitry controlling SNA during emotional stress. PFC, prefrontal cortex; IC, insular cortex; ACC, anterior cingulate cortex; AMY, amygdala; DMH, dorsomedial hypothalamus; PVN, paraventricular nucleus; RVLM, rostral ventrolateral medulla; CVLM, caudal ventrolateral medulla; NTS, nucleus of the solitary tract; SPN, sympathetic preganglionic neurons. See text for additional information.
In addition to the descending excitatory and inhibitory projections controlling sympathetic activity outlined above, sympathetic preganglionic neurons within the IML receive extensive input from intraspinal networks [31][32]. Spinal circuits can contribute both to baseline and reflex responses in sympathetic activity. Resting sympathetic activity and blood pressure are maintained (albeit at a lower level), following cervical or thoracic spinal cord transection and they can be further reduced by ganglionic blockade [24][25]. Although tonically low, sympathetic activity can be markedly increased following the activation of spinal sympathetic pathways. The spinal sympathetic reflex circuitry is similar in composition to the spinal motor reflex circuits that drive muscle contraction in response to muscle stretch or cutaneous stimulation, and like spinal motor reflexes, the spinal sympathetic reflexes are exaggerated by spinal cord transection [33][34][35][36][37]. The spinal motoneurons are controlled by the descending corticothalamic projections, which exhibit a tonic inhibitory drive to the motoneurons [38][39].

3. Basic Neurocircuitry of Nociception

Based on the presence of thermal, chemical, or mechanical stimuli, the signal is detected by specialized receptors (nociceptors) expressed on peripheral terminals of small thinly myelinated or unmyelinated A-delta and C fibers of primary afferent neurons, respectively [40][41]. These afferents carry nociceptive information into laminae I-III of the dorsal horn of the spinal cord where they undergo complex processing. The excitatory and inhibitory interneuronal circuitry integrates incoming information and transmits it to projecting neurons for relay to the brain. Nociceptive information travels to the brain via the contralateral spinothalamic tract synapsing within the ventromedial and mediodorsal nuclei of the thalamus [42]. The nociceptive information also reaches the medulla and brainstem centers via the spinoreticular and spinomesencephalic tracts and the hypothalamus via the spinohypothalamic tract [43]. For the processing of nociceptive signals, especially important is the NTS, which integrates ascending noxious and non-noxious information and provides an interface between sensory and autonomic outflows. The NTS has dense projections with other sub-cortical brain regions such as periaqueductal gray, nucleus raphe magnus, and the hypothalamic nuclei, all of which are also involved in autonomic processing [42]. Finally, nociceptive information is subjected to processing at the cortical level where pain is conceptualized through localization and intensity discrimination. Regarding its localization, somatosensory cortices I and II are mostly responsible for determining the position of nociceptive stimulus while anterior cingulate cortex is involved in assigning an affective component to the pain [44][45].

4. The Relationship between Blood Pressure and Acute Pain Sensitivity

In pain-free individuals, there is a linear, inverse (negative) relationship between blood pressure and acute pain sensitivity [46][47][48][49][50][51][52][53][54][55][56]. Importantly, the diminished acute pain sensitivity association with elevated resting blood pressure involves the medullary baroreflex circuitry, reducing both SNA and pain processing in response to increases in systemic blood pressure. In animals, baroreceptor stimulation induces antinociception [57][58][59], and surgical denervation of baroreceptor afferents produces hyperalgesia [60][61][62]. In humans, stimulation of baroreceptors (e.g., via application of external suction to the carotid artery) reduces acute pain sensitivity [63][64][65][66]. Consistent with the notion that baroreceptor loading is greatest during systole and lowest during diastole, pain sensitivity to ultra-rapid electrical pain stimuli was found to be lowest during systole and the greatest during diastole [67][68]. Altogether, these studies indicate that in addition to reducing SNA, baroreceptor stimulation triggers descending pain inhibitory activity, which contributes to the inverse relationship between resting blood pressure and acute pain.

5. Chronic Pain as a Driver of SNS Overactivation

As introduced above, spinal sympathetic reflex arcs result in the direct activation of sympathetic preganglionic neurons within the IML by ascending sensory/nociceptive pathways. This likely represents the most straightforward neural mechanism by which chronic pain can drive SNS overactivation. Within the dorsal horn, sensory information is directed to: (i) interneurons, which terminate within the same spinal segment, (ii) propriospinal neurons, which terminate within a different spinal segment, and (iii) projecting neurons, which terminate within supraspinal structures. Activation of sympathetic preganglionic neurons occurs either via second-order interneurons, second-order propriospinal neurons, or second-order spinothalamic projecting neurons, which have extensive axon collaterals within the thoracic spinal cord [69]. Additional interneurons (third order) terminating within the intermediolateral cell column of the spinal cord are likely critical for sensory-sympathetic coupling, as second-order neurons (arising from the dorsal horn) rarely make direct connections with cell bodies of sympathetic preganglionic neurons [70]. Thus, in the setting of chronic pain, SNS overactivation may result directly from excess spinal nociceptive input via a spinal sympathetic reflex arc.
A second mechanism by which chronic pain may increase sympathetic activity is secondary to chronic cognitive or emotional stress. Excessive sympathetic stress responses are associated with numerous human disorders, including post-traumatic stress disorder, cerebral palsy, traumatic brain injury, autism spectrum disorders, bipolar disorder, epilepsy, and Charcot–Marie–Tooth disease, among others [71][72][73][74], and can manifest with acute myocardial injury and/or increased susceptibility to sudden cardiac death [75][76][77]. Cardiovascular consequences of stress are similar in all mammals [28][78][79], and chronic or repetitive stress leading to increases in sympathetic activity is one proven cause of hypertension and heart failure [78][80]. Pain, especially when present in a chronic form, is a source of discomfort and substantial emotional suffering. In chronic orofacial pain patients, sympathetic responses to mental stressors are significantly greater than responses in pain-free, age and sex-matched controls [81].

6. Maladaptive Changes in the Neural Circuitry Leading to Sympathetic Overactivation and Chronic Pain

Our understanding of neuroplastic changes associated with chronic pain has been largely made possible by advancements in in vivo imaging using magnetic resonance imaging (MRI) techniques. Enhanced spatial resolution and contrast enable detailed structural morphology studies to be conducted in patients with chronic pain. Functional magnetic resonance imaging (fMRI) studies in humans have demonstrated the coordinated activation of several brain areas in response to noxious somatic and visceral stimuli, including the thalamus, anterior cingulate cortex, insular cortex, primary and secondary sensory cortices, prefrontal cortex, basal ganglia, cerebellum, and amygdala. This network of brain regions involved in both sensory discriminative and emotional-affective aspects of pain is termed the “pain matrix” [82].
Chronic pain is associated with plastic changes at every level of the neural axis including primary sensory endings, as well as spinal and supraspinal sites [83]. The changes within the supraspinal centers are particularly important as they may contribute to altered nociceptive processing and perception of pain. Given the anatomical and functional overlap between the central nociceptive and central autonomic networks, the aberrant changes that occur within the supraspinal centers may simultaneously manifest with dysregulated sympathetic control and chronic pain. Recent studies have found that chronic pain sufferers irrespective of the origin of pain, exhibit common brain signatures associated with the loss of gray matter in cortical and subcortical structures such as the prefrontal and insular cortex, orbitofrontal cortex, and pons [83]. Using connectivity analyses of resting state fMRI, chronic migraine sufferers exhibited reduced gray matter volume and reduced cortical thickness in brain regions involved in the affective processing of pain including dlPFC [84]. 

References

  1. Malpas, S.C. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol. Rev. 2010, 90, 513–557.
  2. Rozanski, A.; Blumenthal, J.A.; Kaplan, J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999, 99, 2192–2217.
  3. Maixner, W.; Sigurdsson, A.; Fillingim, R.; Lundeen, T.; Booker, D. Regulation of acute and chronic orofacial pain. In Orofacial Pain and Temopromandibular Disorders; Raven Press: New York, NY, USA, 1995; pp. 85–102.
  4. Bruehl, S.; Chung, O.Y.; Ward, P.; Johnson, B.; McCubbin, J.A. The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: The effects of opioid blockade. Pain 2002, 100, 191–201.
  5. Bruehl, S.; Burns, J.W.; McCubbin, J.A. Altered cardiovascular/pain regulatory relationships in chronic pain. Int. J. Behav. Med. 1998, 5, 63–75.
  6. Brody, S.; Angrilli, A.; Weiss, U.; Birbaumer, N.; Mini, A.; Veit, R.; Rau, H. Somatotosensory evoked potentials during baroreceptor stimulation in chronic low back pain patients and normal controls. Int. J. Psychophysiol. 1997, 25, 201–210.
  7. Perry, F.; Heller, P.H.; Kamiya, J.; Levine, J.D. Altered autonomic function in patients with arthritis or with chronic myofascial pain. Pain 1989, 39, 77–84.
  8. Hjemdahl, P.; Larsson, P.; Wallen, N. Effects of stress and beta-blockade on platelet function. Circulation 1991, 84, VI44–VI61.
  9. Ardlie, N.; Glew, G.; Schwartz, C. Influence of catecholamines on nucleotide-induced platelet aggregation. Nature 1966, 212, 415–417.
  10. O’brien, J. Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature 1963, 200, 763–764.
  11. Benarroch, E.E. The central autonomic network: Functional organization, dysfunction, and perspective. In Proceedings of Mayo Clinic Proceedings; Elsevier: Amsterdam, The Netherlands, 1993; pp. 988–1001.
  12. Calaresu, F.; Yardley, C. Medullary basal sympathetic tone. Annu. Rev. Physiol. 1988, 50, 511–524.
  13. Guertzenstein, P.; Silver, A. Fall in blood pressure produced from discrete regions of the ventral surface of the medulla by glycine and lesions. J. Physiol. 1974, 242, 489–503.
  14. Stein, R.; Weaver, L.; Yardley, C. Ventrolateral medullary neurones: Effects on magnitude and rhythm of discharge of mesenteric and renal nerves in cats. J. Physiol. 1989, 408, 571–586.
  15. Guyenet, P.G.; Haselton, J.R.; Sun, M.-K. Sympathoexcitatory neurons of the rostroventrolateral medulla and the origin of the sympathetic vasomotor tone. Prog. Brain Res. 1989, 81, 105–116.
  16. Sakima, A.; Yamazato, M.; Sesoko, S.; Muratani, H.; Fukiyama, K. Cardiovascular and sympathetic effects of L-glutamate and glycine injected into the rostral ventrolateral medulla of conscious rats. Hypertens. Res. 2000, 23, 633–641.
  17. Willette, R.; Barcas, P.; Krieger, A.; Sapru, H.N. Vasopressor and depressor areas in the rat medulla: Identification by microinjection of L-glutamate. Neuropharmacology 1983, 22, 1071–1079.
  18. Dampney, R.; Moon, E.A. Role of ventrolateral medulla in vasomotor response to cerebral ischemia. Am. J. Physiol.-Heart Circ. Physiol. 1980, 239, H349–H358.
  19. Sun, M.-K.; Reis, D.J. Central neural mechanisms mediating excitation of sympathetic neurons by hypoxia. Prog. Neurobiol. 1994, 44, 197–219.
  20. Kubo, T.; Goshima, Y.; Hata, H.; Misu, Y. Evidence that endogenous catecholamines are involved inα2-adrenoceptor-mediated modulation of the aortic baroreceptor reflex in the nucleus tractus solitarii of the rat. Brain Res. 1990, 526, 313–317.
  21. Lawrence, A.J.; Jarrott, B. Neurochemical modulation of cardiovascular control in the nucleus tractus solitarius. Prog. Neurobiol. 1996, 48, 21–53.
  22. Murase, S.; Inui, K.; Nosaka, S. Baroreceptor inhibition of the locus coeruleus noradrenergic neurons. Neuroscience 1994, 61, 635–643.
  23. Morrison, S.F. RVLM and raphe differentially regulate sympathetic outflows to splanchnic and brown adipose tissue. Am. J. Physiol. 1999, 276, R962–R973.
  24. Reynolds, C.A.; O’Leary, D.S.; Ly, C.; Smith, S.A.; Minic, Z. Development of a decerebrate model for investigating mechanisms mediating viscero-sympathetic reflexes in the spinalized rat. Am. J. Physiol.-Heart Circ. Physiol. 2019, 316, H1332–H1340.
  25. Mayorov, D.N.; Adams, M.A.; Krassioukov, A.V. Telemetric blood pressure monitoring in conscious rats before and after compression injury of spinal cord. J. Neurotrauma 2001, 18, 727.
  26. Osborn, J.W.; Taylor, R.F.; Schramm, L.P. Determinants of arterial pressure after chronic spinal transection in rats. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 1989, 256, R666–R673.
  27. Hayes, K.; Yardley, C.; Weaver, L. Evidence for descending tonic inhibition specifically affecting sympathetic pathways to the kidney in rats. J. Physiol. 1991, 434, 295–306.
  28. Fontes, M.; Tagawa, T.; Polson, J.; Cavanagh, S.-J.; Dampney, R. Descending pathways mediating cardiovascular response from dorsomedial hypothalamic nucleus. Am. J. Physiol.-Heart Circ. Physiol. 2001, 280, H2891–H2901.
  29. Cao, W.H.; Fan, W.; Morrison, S.F. Medullary pathways mediating specific sympathetic responses to activation of dorsomedial hypothalamus. Neuroscience 2004, 126, 229–240.
  30. Martin, D.S.; Segura, T.; Haywood, J.R. Cardiovascular responses to bicuculline in the paraventricular nucleus of the rat. Hypertension 1991, 18, 48–55.
  31. Chau, D.; Johns, D.G.; Schramm, L.P. Ongoing and stimulus-evoked activity of sympathetically correlated neurons in the intermediate zone and dorsal horn of acutely spinalized rats. J. Neurophysiol. 2000, 83, 2699–2707.
  32. Barman, S.M.; Gebber, G.L. Spinal interneurons with sympathetic nerve-related activity. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 1984, 247, R761–R767.
  33. Sherrington, C.; Laslett, E. Observations on some spinal reflexes and the interconnection of spinal segments. J. Physiol. 1903, 29, 58.
  34. Miller, F.R. Viscero-motor reflexes. II. Am. J. Physiol.-Leg. Content 1924, 71, 84–89.
  35. Miller, F.R.; Waud, R. Viscero-motor reflexes. IV. Am. J. Physiol.-Leg. Content 1925, 73, 329–340.
  36. Downman, C.; McSwiney, B. Reflexes elicited by visceral stimulation in the acute spinal animal. J. Physiol. 1946, 105, 80.
  37. Minic, Z.; O’Leary, D.S.; Reynolds, C.A. Spinal reflex control of arterial blood pressure: The role of TRP channels and their endogenous eicosanoid modulators. Front. Physiol. 2022, 13, 838175.
  38. Jankowska, E.; Padel, Y.; Tanaka, R. Disynaptic inhibition of spinal motoneurones from the motor cortex in the monkey. J. Physiol. 1976, 258, 467–487.
  39. Triggs, W.J.; Macdonell, R.A.; Cros, D.; Chiappa, K.H.; Shahani, B.T.; Day, B.J. Motor inhibition and excitation are independent effects of magnetic cortical stimulation. Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 1992, 32, 345–351.
  40. Bennett, G.J. Update on the neurophysiology of pain transmission and modulation: Focus on the NMDA-receptor. J. Pain Symptom Manag. 2000, 19, 2–6.
  41. Sandkühler, J.; Bromm, B.; Gebhart, G.F. Nervous System Plasticity and Chronic Pain; Elsevier Science Limited: Amsterdam, The Netherlands, 2000; Volume 129.
  42. Craig, A.D. Pain mechanisms: Labeled lines versus convergence in central processing. Annu. Rev. Neurosci. 2003, 26, 1–30.
  43. Brooks, J.; Tracey, I. From nociception to pain perception: Imaging the spinal and supraspinal pathways. J. Anat. 2005, 207, 19–33.
  44. Bushnell, M.C.; Duncan, G.H.; Hofbauer, R.K.; Ha, B.; Chen, J.I.; Carrier, B. Pain perception: Is there a role for primary somatosensory cortex? Proc. Natl. Acad. Sci. USA 1999, 96, 7705–7709.
  45. Rainville, P.; Duncan, G.H.; Price, D.D.; Carrier, B.; Bushnell, M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997, 277, 968–971.
  46. Bruehl, S.; Carlson, C.R.; McCubbin, J.A. The relationship between pain sensitivity and blood pressure in normotensives. Pain 1992, 48, 463–467.
  47. Bruehl, S.; Chung, O.Y. Interactions between the cardiovascular and pain regulatory systems: An updated review of mechanisms and possible alterations in chronic pain. Neurosci. Biobehav. Rev. 2004, 28, 395–414.
  48. McCubbin, J.A.; Bruehl, S. Do endogenous opioids mediate the relationship between blood pressure and pain sensitivity in normotensives? Pain 1994, 57, 63–67.
  49. Fillingim, R.B.; Maixner, W. The influence of resting blood pressure and gender on pain responses. Psychosom. Med. 1996, 58, 326–332.
  50. Pfleeger, M.; Straneva, P.A.; Fillingim, R.B.; Maixner, W.; Girdler, S.S. Menstrual cycle, blood pressure and ischemic pain sensitivity in women: A preliminary investigation. Int. J. Psychophysiol. 1997, 27, 161–166.
  51. Fillingim, R.B.; Maixner, W.; Bunting, S.; Silva, S. Resting blood pressure and thermal pain responses among females: Effects on pain unpleasantness but not pain intensity. Int. J. Psychophysiol. 1998, 30, 313–318.
  52. Myers, C.D.; Robinson, M.E.; Riley III, J.L.; Sheffield, D. Sex, gender, and blood pressure: Contributions to experimental pain report. Psychosom. Med. 2001, 63, 545–550.
  53. Al’Absi, M.; Buchanan, T.; Lovallo, W.R. Pain perception and cardiovascular responses in men with positive parental history for hypertension. Psychophysiology 1996, 33, 655–661.
  54. Al’Absi, M.; Buchanan, T.W.; Marrero, A.; Lovallo, W.R. Sex differences in pain perception and cardiovascular responses in persons with parental history for hypertension. Pain 1999, 83, 331–338.
  55. al’Absi, M.; Petersen, K.L.; Wittmers, L.E. Blood pressure but not parental history for hypertension predicts pain perception in women. Pain 2000, 88, 61–68.
  56. al’Absi, M.; Petersen, K.L.; Wittmers, L.E. Adrenocortical and hemodynamic predictors of pain perception in men and women. Pain 2002, 96, 197–204.
  57. Randich, A.; Maixner, W. Interactions between cardiovascular and pain regulatory systems. Neurosci. Biobehav. Rev. 1984, 8, 343–367.
  58. Takeda, M.; Tanimoto, T.; Ojima, K.; Matsumoto, S. Suppressive effect of vagal afferents on the activity of the trigeminal spinal neurons related to the jaw-opening reflex in rats: Involvement of the endogenous opioid system. Brain Res. Bull. 1998, 47, 49–56.
  59. Bossut, D.; Maixner, W. Effects of cardiac vagal afferent electrostimulation on the responses of trigerninal and trigeminothalamic neurons to noxious orofacial stimulation. Pain 1996, 65, 101–109.
  60. Dworkin, B.; Filewich, R.; Miller, N.; Craigmyle, N.; Pickering, T. Baroreceptor activation reduces reactivity to noxious stimulation: Implications for hypertension. Science 1979, 205, 1299–1301.
  61. Thurston, C.L.; Randich, A. Acute increases in arterial blood pressure produced by occlusion of the abdominal aorta induces antinociception: Peripheral and central substrates. Brain Res. 1990, 519, 12–22.
  62. Maixner, W.; Touw, K.B.; Brody, M.J.; Gebhart, G.F. Factors influencing the altered pain perception in the spontaneously hypertensive rat. Brain Res. 1982, 237, 137–145.
  63. D’Antono, B.; Ditto, B.; Sita, A.; Miller, S.B. Cardiopulmonary baroreflex stimulation and blood pressure-related hypoalgesia. Biol. Psychol. 2000, 53, 217–231.
  64. Dworkin, B.R.; Elbert, T.; Rau, H.; Birbaumer, N.; Pauli, P.; Droste, C.; Brunia, C. Central effects of baroreceptor activation in humans: Attenuation of skeletal reflexes and pain perception. Proc. Natl. Acad. Sci. USA 1994, 91, 6329–6333.
  65. Rau, H.; Brody, S.; Larbig, W.; Pauli, P.; Vöhringer, M.; Harsch, B.; Kröling, P.; Birbaumer, N. Effects of PRES baroreceptor stimulation on thermal and mechanical pain threshold in borderline hypertensives and normotensives. Psychophysiology 1994, 31, 480–485.
  66. Angrilli, A.; Mini, A.; Mucha, R.F.; Rau, H. The influence of low blood pressure and baroreceptor activity on pain responses. Physiol. Behav. 1997, 62, 391–397.
  67. Edwards, L.; McIntyre, D.; Carroll, D.; Ring, C.; France, C.R.; Martin, U. Effects of artificial and natural baroreceptor stimulation on nociceptive responding and pain. Psychophysiology 2003, 40, 762–769.
  68. Edwards, L.; Ring, C.; McIntyre, D.; Carroll, D. Modulation of the human nociceptive flexion reflex across the cardiac cycle. Psychophysiology 2001, 38, 712–718.
  69. Browne, T.J.; Hughes, D.I.; Dayas, C.V.; Callister, R.J.; Graham, B.A. Projection neuron axon collaterals in the dorsal horn: Placing a new player in spinal cord pain processing. Front. Physiol. 2020, 11, 560802.
  70. Schramm, L.P. Spinal sympathetic interneurons: Their identification and roles after spinal cord injury. Prog. Brain Res. 2006, 152, 27–37.
  71. Clifton, G.L.; Ziegler, M.G.; Grossman, R.G. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery 1981, 8, 10–14.
  72. Park, E.S.; Park, C.I.; Cho, S.R.; Lee, J.W.; Kim, E.J. Assessment of autonomic nervous system with analysis of heart rate variability in children with spastic cerebral palsy. Yonsei Med. J. 2002, 43, 65–72.
  73. Kushki, A.; Drumm, E.; Mobarak, M.P.; Tanel, N.; Dupuis, A.; Chau, T.; Anagnostou, E. Investigating the autonomic nervous system response to anxiety in children with autism spectrum disorders. PLoS ONE 2013, 8, e59730.
  74. Appelhans, B.M.; Luecken, L.J. Heart rate variability as an index of regulated emotional responding. Rev. Gen. Psychol. 2006, 10, 229.
  75. Webb, S.; Adgey, A.; Pantridge, J. Autonomic disturbance at onset of acute myocardial infarction. Br. Med. J. 1972, 3, 89–92.
  76. Schwartz, P.J.; Vanoli, E. Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: A new experimental model for the study of antiarrhythmic drugs. J. Cardiovasc. Pharmacol. 1981, 3, 1251–1259.
  77. Lyon, A.R.; Rees, P.S.; Prasad, S.; Poole-Wilson, P.A.; Harding, S.E. Stress (Takotsubo) cardiomyopathy—A novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat. Rev. Cardiol. 2008, 5, 22.
  78. Esler, M.; Lambert, G.; Brunner-La Rocca, H.; Vaddadi, G.; Kaye, D. Sympathetic nerve activity and neurotransmitter release in humans: Translation from pathophysiology into clinical practice. Acta Physiol. Scand. 2003, 177, 275–284.
  79. Schadt, J.C.; Ludbrook, J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am. J. Physiol. -Heart Circ. Physiol. 1991, 260, H305–H318.
  80. Evans, R.G.; Ventura, S.; Dampney, R.A.; Ludbrook, J. John Ludbrook APPS Symposium Neural Mechanisms In The Cardiovascular Responses To Acute Central Hypovolaemia. Clin. Exp. Pharmacol. Physiol. 2001, 28, 479–487.
  81. Carlson, C.R.; Okeson, J.P.; Falace, D.A.; Nitz, A.J.; Curran, S.L.; Anderson, D. Comparison of psychologic and physiologic functioning between patients with masticatory muscle pain and matched controls. J. Orofac. Pain 1993, 7.
  82. Schweinhardt, P.; Bushnell, M.C. Pain imaging in health and disease—How far have we come? J. Clin. Investig. 2010, 120, 3788–3797.
  83. May, A. Chronic pain may change the structure of the brain. PAIN® 2008, 137, 7–15.
  84. Hubbard, C.S.; Khan, S.A.; Keaser, M.L.; Mathur, V.A.; Goyal, M.; Seminowicz, D.A. Altered brain structure and function correlate with disease severity and pain catastrophizing in migraine patients. Eneuro 2014, 1.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Physiology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Christian A. Reynolds
,
Zeljka Minic
View Times: 361
Revisions: 2 times (View History)
Update Date: 13 Apr 2023
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback